Abstract
A possible association between HLA antigens and carcinoma of the prostate was searched for in 20 patients and 200 healthy kidney donors. HLA antigens A26, A28, B13, B14, B40, Bw4 and Cw4 were more common in patients with carcinoma of the prostate. The relative risk for HLA B14 was 7.78 (95% confidence interval 7.60–8.13). The relative risk for patients carrying the above antigens (except A28) was higher than 2. This study shows that certain HLA antigens may be more frequent in patients with carcinoma of the prostate. Before drawing any conclusions from these findings, they have to be confirmed by other studies.
Similar content being viewed by others
References
Svejgaard, A., Platz, P., Ryder, L. P.: HLA and disease, 1982. A survey.Immunol. Res., 70, 193 (1983).
Terasaki, P. I., Perdue, S. T., Mickey, H. D.: HLA frequencies in cancer. A second study. In: Mulvihill, J. T., Miller, R. W., Franmeni, J. P. (eds): Genetics of Human Cancer. Raven Press, New York 1977, pp. 321–328.
Terasaki, P. I., Benaco, D., Park, M. S.: Microdroplet testing for HLA A, B, C and D.Am. J. Clin. Pathol., 69, 103 (1978).
Green, A.: The epidemiological approach to studies of association between HLA and disease. II. Estimation of absolute risk, etiologic and preventive factors.Tissue Antigens, 19, 245 (1982).
Barry, J. M., Goldstein, A., Hubbard, M.: Human leukocyte A and B antigens in patients with prostatic adenocarcinoma.J. Urol., 124, 847 (1980).
Svejgaard, A., Platz, P., Ryder, L. P.: HLA and disease association. A survey.Transplant Rev., 22, 3 (1975).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kirkali, Z., Eryiğit, M. Carcinoma of the prostate and HLA antigens. International Urology and Nephrology 23, 573–576 (1991). https://doi.org/10.1007/BF02549848
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02549848